Company Overview: PCG Advisory

PCG Advisory

13 Oct

PCG Advisory Group CEO Jeff Ramson Leads Panel at The MicroCap Conference on “Hot Topics in Blockchain Technologies and Cryptocurrencies”

PCG Advisory Group CEO Jeff Ramson Leads Panel at The MicroCap Conference on “Hot Topics in Blockchain Technologies and Cryptocurrencies” NEW YORK, NY–(Marketwired – Oct 12, 2017) – PCG Advisory Group, a leading investor relations and digital strategies firm, today announced that Founder and CEO, Jeff Ramson, moderated a panel...

Read more

8 Sep

PCG Advisory Group Announces Client Availability at the Rodman and Renshaw 19th Annual Global Investment Conference

–14 Clients Available for Investor Introductions–   NEW YORK, NY — 09/8/17 — PCG Advisory Group (PCG), a leading investor relations and integrated communications firm specializing in digital and social media strategies, announced today that 14 clients will be participating in the Rodman & Renshaw 19th Annual Global Investment Conference, New...

Read more

9 Feb

PCG Advisory Group Appoints Howard Gostfrand as Senior Advisor

NEW YORK, NY / ACCESSWIRE / February 9, 2017 / PCG Advisory Group, a New York-based leading investor and public relations firm, today announced that it has appointed Howard Gostfrand, President of American Capital Ventures, as a Senior Advisor. “Howard Gostfrand’s experience and ties to the investment community will...

Read more

22 Dec

PCG Advisory Group (PCG) Announces Clients Participating During the 9th Annual Biotech Showcase(TM) Event and the 35th Annual J.P. Morgan Healthcare Conference in San Francisco

NEW YORK, NY / ACCESSWIRE / December 22, 2016 / PCG Advisory Group, a New York based leading investor and public relations firm, announces clients that will be participating in industry events around the upcoming J.P. Morgan Healthcare Conference and 9th Annual Biotech Showcase Event, which are taking place...

Read more

21 Dec

PCG Client Availability in San Francisco, CA

PCG Client Availability in San Francisco, CA January 9 – 12, 2017 To Schedule 1×1 Management Meetings, Please Contact: Kirin Smith: ksmith@pcgadvisory.com – 646-863-6519 Adam Holdsworth: adamh@pcgadvisory.com – 646-862-4607 Abeona Therapeutics (NASDAQ: ABEO) $290mn Mcap, ~$75mn cash Clinical stage bio-pharma company developing gene and plasma-based therapies for life-threatening rare genetic diseases Lead programs are adeno-associated virus...

Read more

Page 1 of 41234

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address